OTR Global upgrades Check Point Software (NASDAQ:CHKP) from Mixed to Positive.
RBC Capital Initiates Coverage On ADC Therapeutics with Outperform Rating, Announces Price Target of $33
RBC Capital analyst Kennen MacKay initiates coverage on ADC Therapeutics (NYSE:ADCT) with a Outperform rating and announces Price Target of $33.